Clinical Trial Update: Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating cabozantinib plus docetaxel and prednisone in advanced prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostatic Neoplasms

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PREDNISONE (Prednisone)
• cabozantinib (cabozantinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-11-08